• Reuters, Bloomberg

  • SHARE

The government is in talks with U.S. health care conglomerate Johnson & Johnson about securing allocations of its potential COVID-19 vaccine as the company prepares to kick off human trials, the firm’s Chief Financial Officer Joseph Wolk said in an interview.

More than a hundred vaccines are under development to try and stop the COVID-19 pandemic, and drugmakers including J&J are working to ramp up their supplies of their vaccines in the face of unprecedented demand.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)